angiotensin ii has been researched along with thiazolidines in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Iso, T; Iwao, J; Nishimura, K; Oya, M | 1 |
| Ayajiki, K; Okamura, T; Okunishi, H; Toda, N | 1 |
| Miyazaki, M; Okamura, T; Okunishi, H; Toda, N | 1 |
| Higashimori, K; Inagami, T; Mizuno, K; Nakamaru, M | 1 |
| Miyazaki, M; Okunishi, H; Toda, N | 1 |
| Funae, Y; Komori, T; Sasaki, D; Yamamoto, K | 1 |
| Bönner, G; Ganten, D; Rascher, W; Rockhold, RW; Schaz, K; Schömig, A; Speck, G; Unger, T | 1 |
| Adachi, Y; Karaki, H; Satake, N; Sato, K; Shibata, S | 1 |
| Albinsson, S; Hellstrand, P; Malmqvist, U; Nordström, I; Swärd, K; Zeidan, A | 1 |
| Becq, F; Norez, C; Robert, R | 1 |
| Charles, R; Claing, A; Cotton, M; Laporte, SA; Namkung, Y | 1 |
| Aoyama, M; Bando, YK; Kawase, H; Monji, A; Murohara, T; Nishimura, K | 1 |
| Deguchi, H; Enzan, N; Ide, T; Ikeda, M; Ikeda, S; Ishikita, A; Matsushima, S; Okabe, K; Sada, M; Shinohara, K; Tadokoro, T; Tsutsui, H; Yamamoto, T | 1 |
13 other study(ies) available for angiotensin ii and thiazolidines
| Article | Year |
|---|---|
Potentiating mechanism of bradykinin action on smooth muscle by sulfhydryl compounds.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Animals; Bradykinin; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Sulfhydryl Compounds; Thiazoles; Thiazolidines; Time Factors | 1979 |
Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Dogs; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Isometric Contraction; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Oligopeptides; Peptidyl-Dipeptidase A; Renal Artery; Serine Endopeptidases; Thiazolidines; Tranylcypromine | 1990 |
Elevated vascular angiotensin converting enzyme in chronic two-kidney, one clip hypertension in the dog.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Male; Muscle Contraction; Peptidyl-Dipeptidase A; Renin; Thiazolidines | 1987 |
Local generation and release of angiotensin II in peripheral vascular tissue.
Topics: 3-Mercaptopropionic Acid; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chromatography, High Pressure Liquid; Hindlimb; Male; Muscle, Smooth, Vascular; Perfusion; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Thiazolidines | 1988 |
Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Blood Vessels; Dogs; Female; In Vitro Techniques; Macaca; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oligopeptides; Sulfhydryl Compounds; Thiazolidines | 1984 |
Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; In Vitro Techniques; Kinetics; Norepinephrine; Pentobarbital; Pentolinium Tartrate; Rabbits; Renin; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1980 |
Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
Topics: 3-Mercaptopropionic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Catecholamines; Hypertension; Male; Rats; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1981 |
Mechanisms of vasoinhibitory effect of cardioprotective agent, CP-060S, in rat aorta.
Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Cytosol; Dinoprost; Drug Interactions; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Rats; Rats, Wistar; Thiazoles; Thiazolidines; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors.
Topics: Actins; Angiotensin II; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Differentiation; Culture Techniques; Cytochalasin D; Cytoskeleton; Enzyme Activation; Enzyme Inhibitors; Female; MAP Kinase Signaling System; Microfilament Proteins; Muscle Contraction; Muscle Proteins; Muscle, Smooth, Vascular; Nucleic Acid Synthesis Inhibitors; Portal Vein; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; Stress, Mechanical; Thiazoles; Thiazolidines | 2003 |
Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl- transport of mouse aortic smooth muscle cells.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Aorta, Thoracic; Benzoates; Cells, Cultured; Chlorides; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Genistein; Glyburide; In Vitro Techniques; Isoproterenol; Mice; Mice, Inbred CFTR; Muscle, Smooth, Vascular; ortho-Aminobenzoates; Quinolizines; Serotonin; Thiazoles; Thiazolidines; Vasoactive Intestinal Peptide; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2005 |
β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Angiotensin II; Animals; Arrestins; beta-Arrestins; Cell Movement; Endocytosis; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Wistar; Receptors, Angiotensin; Sulfonamides; Thiazolidines | 2016 |
A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
Topics: Angiotensin II; Animals; Blood Pressure; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Echocardiography; Heart Failure; Hypertension; Male; Myocytes, Cardiac; Pyrazoles; Rats; Rats, Inbred SHR; Signal Transduction; Sodium-Hydrogen Exchangers; Thiazolidines; Vasodilation; Ventricular Remodeling | 2016 |
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathw
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Heart Rate; Histone Deacetylases; Mice; Myocytes, Cardiac; NADPH Oxidase 4; Oxidative Stress; Pyrazoles; Rats; Signal Transduction; Thiazolidines | 2020 |